申请人:Yamanouchi Pharmaceutical Co., Ltd.
公开号:US05442110A1
公开(公告)日:1995-08-15
##STR1## A compound represented by general formula (I), a pharmaceutical composition containing same, a process for the production thereof, and an intermediate therefor. In formula (I) R.sup.1 represents lower alkyl which may be substituted by a substituent selected from the group consisting of mercapto, lower alkylthio, arylthio and lower acylthio; R.sup.2, R.sup.3 and R.sup.4 may be the same or different from one another and each represents lower alkyl; X represents oxygen or sulfur; and Y represents a single bond or lower alkylene. The compound (I) has a matrix metalloprotease inhibitory activity and is useful for preventing and treating diseases caused by the progress of connective tissue breakage.
化合物的通式(I),包含该化合物的制药组合物,其制备方法以及中间体。在式(I)中,R.sup.1代表可以被来自汞、低级烷基硫、芳基硫和低级酰基硫的取代基取代的低级烷基;R.sup.2、R.sup.3和R.sup.4可以相同,也可以不同,且每个都代表低级烷基;X代表氧或硫;Y代表单键或低级烷基。该化合物(I)具有基质金属蛋白酶抑制活性,可用于预防和治疗由于结缔组织断裂进展而引起的疾病。